Literature DB >> 7533177

Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes.

N Burdin1, C Van Kooten, L Galibert, J S Abrams, J Wijdenes, J Banchereau, F Rousset.   

Abstract

This study was initiated to explore the contribution of endogenous cytokines to CD40-induced B cell proliferation and differentiation. First, both CD40 and Ag receptor (AgR) cross-linking induced purified tonsillar human B lymphocytes to secrete the same pattern of cytokines, including IL-1 beta, IL-6, IL-10, granulocyte-macrophage-CSF, and TNF-alpha, whereas IL-1 alpha, IL-2, IL-3, IL-4, IL-5, IL-7, granulocyte (G)-CSF, or IFN-gamma were not detected. Second, cotriggering of CD40 and AgR resulted in additive secretion of both IL-6 and IL-10. Addition of IL-4 to CD40-activated B cells increased IL-6 levels but decreased IL-10 levels. In contrast, exogenous IL-10 diminished IL-6 levels. Neutralization of IL-6 and IL-10 using blocking Abs did not alter CD40-induced B cell growth. In contrast, IL-6 neutralization markedly inhibited the IL-4-induced IgE secretion (57 +/- 10%) as well as the IgG and IgM production resulting from AgR and CD40 cotriggering (49 +/- 16.5 and 29.5 +/- 4.5%, respectively). Blocking IL-10 inhibited the IgA secretion (25 +/- 2.7%) obtained after CD40 activation and the production of IgG, IgA, and IgM (24.1 +/- 5.6, 25 +/- 8, and 42 +/- 6.5%, respectively) by B lymphocytes undergoing dual ligation of CD40 Ag and AgR. Simultaneous neutralization of both endogenous IL-6 and IL-10 resulted in an increased inhibition of Ig secretion for B cells cotriggered by CD40 Ag and AgR (65-75%). Thus, endogenously produced IL-6 and IL-10 are involved in the differentiation of CD40-activated B cell.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533177

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.

Authors:  Daniel Traum; Patricia Timothee; Jonathan Silver; Stefan Rose-John; Matthias Ernst; David F LaRosa
Journal:  J Leukoc Biol       Date:  2011-12-02       Impact factor: 4.962

2.  Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation.

Authors:  A Greiner; C Knörr; Y Qin; W Sebald; A Schimpl; J Banchereau; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Expression of costimulatory molecules in low-grade mucosa-associated lymphoid tissue-type lymphomas in vivo.

Authors:  C Knörr; C Amrehn; H Seeberger; A Rosenwald; S Stilgenbauer; G Ott; H K Müller Hermelink; A Greiner
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Association of IL-10 level and IL-10 promoter SNPs with specific antibodies in penicillin-allergic patients.

Authors:  Hai-Ling Qiao; Qiang Wen; Na Gao; Xin Tian; Lin-Jing Jia
Journal:  Eur J Clin Pharmacol       Date:  2007-01-16       Impact factor: 2.953

5.  Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPS-stimulated monocytes/macrophages.

Authors:  Xiaochuan Wang; Cheryl Allen; Mark Ballow
Journal:  J Clin Immunol       Date:  2007-01-26       Impact factor: 8.317

6.  CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-beta: evidence for TGF-beta but not IL-10-dependent direct S mu-->S alpha and sequential S mu-->S gamma, S gamma-->S alpha DNA recombination.

Authors:  H Zan; A Cerutti; P Dramitinos; A Schaffer; P Casali
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

Review 7.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

8.  Impaired T-cell receptor activation in IL-1 receptor-associated kinase-4-deficient patients.

Authors:  Douglas R McDonald; Frederick Goldman; Oscar D Gomez-Duarte; Andrew C Issekutz; Dinakantha S Kumararatne; Rainer Doffinger; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2010-08       Impact factor: 10.793

9.  Complexes between nuclear factor-κB p65 and signal transducer and activator of transcription 3 are key actors in inducing activation-induced cytidine deaminase expression and immunoglobulin A production in CD40L plus interleukin-10-treated human blood B cells.

Authors:  S Lafarge; H Hamzeh-Cognasse; Y Richard; B Pozzetto; M Cogné; F Cognasse; O Garraud
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

Review 10.  B-cell and T-cell epitopes in anti-factor VIII immune responses.

Authors:  Kathleen P Pratt; Arthur R Thompson
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.